ESP Pharma - Ownership and Business Overview

Life ScienceCompany

ESP Pharma Ownership

Who owns ESP Pharma?

ESP Pharma is owned by PDL BioPharma. It was acquired on January 9, 2006.

ESP Pharma Business Overview

Where is ESP Pharma headquartered?

ESP Pharma is headquartered in Edison, New Jersey.

What sector is ESP Pharma in?

ESP Pharma is a life science company.

When was ESP Pharma founded?

ESP Pharma was founded in 2002.

Life Science M&A Summary in 2006

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.

Join Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.

ESP Pharma, Inc.

2035 Lincoln Highway, Suite 2150,
Edison, New Jersey 08817
United States,
(732) 650-1377

ESP Pharma, Inc. is a hospital-focused pharmaceutical company.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.